Axikin Pharmaceuticals (San Diego, CA) an early-stage company focused on the development of of small-molecule therapeutics for respiratory disorders including allergic rhinitis, asthma and CPOD, closed a $3M Series A financing. Participants include Sanderling Ventures and Mitsui & Co. Venture Partners.